• Citer

Correlation of molecular and clinically distinct phenotypes in HER2-overexpressing breast cancer (HER2+ BC) with estrogen receptor status (ER) status: Implications for anti-HER2 therapy

par Loi, Sherene ;Haibe-Kains, Benjamin ;Brown, David Norman ;Metallo, Jessica;Huan, LX;Desmedt, Christine ;Pusztai, Lajos;Piccart-Gebhart, Martine ;Esteva, Francisco J;Sotiriou, Christos
Référence ASCO Annual Meeting(June 4-8, 2010: Chicago, Il, USA), Journal of Clinical Oncology, 2010 ASCO Annual Meeting Proceedings, Vol. Vol 28, Issue 15s, Suppl
Publication Publié, 2010

Abstract de conférence

• Détails
• Contenu

Titre:	Correlation of molecular and clinically distinct phenotypes in HER2-overexpressing breast cancer (HER2+ BC) with estrogen receptor status (ER) status: Implications for anti-HER2 therapy
Auteur:	Loi, Sherene; Haibe-Kains, Benjamin; Brown, David Norman; Metallo, Jessica; Huan, LX; Desmedt, Christine; Pusztai, Lajos; Piccart-Gebhart, Martine; Esteva, Francisco J; Sotiriou, Christos
Informations sur la publication:	ASCO Annual Meeting(June 4-8, 2010: Chicago, Il, USA), Journal of Clinical Oncology, 2010 ASCO Annual Meeting Proceedings, Vol. Vol 28, Issue 15s, Suppl
Statut de publication:	Publié, 2010
Sujet CREF:	Cancérologie
	Médecine pathologie humaine
	Sciences bio-médicales et agricoles
Langue:	Anglais